 | • レポートコード：QYR9ST04891 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、高カルシウム血症治療の世界市場について調査・分析し、高カルシウム血症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ビスホスホネート、グルココルチコイド、カルシウム擬態薬）、用途別（軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の高カルシウム血症治療市場動向 ・主要企業別マーケットシェア ・高カルシウム血症治療の種類別市場規模2014-2019 （ビスホスホネート、グルココルチコイド、カルシウム擬態薬） ・高カルシウム血症治療の用途別市場規模2014-2019 （軽度高カルシウム血症、中等度高カルシウム血症、重度高カルシウム血症） ・高カルシウム血症治療の北米市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療の中国市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療のインド市場：主要企業・種類別/用途別市場規模 ・高カルシウム血症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AbbVie、Amgen、Merck、Novartis、OPKO Health） ・高カルシウム血症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.
The growing preference for combination therapy is estimated to drive the growth prospects for the global hypercalcemia treatment market until the end of 2023. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.
In 2018, the global Hypercalcemia Treatment market size was 8590 million US$ and it is expected to reach 19100 million US$ by the end of 2025, with a CAGR of 10.5% during 2019-2025.
This report focuses on the global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypercalcemia Treatment development in United States, Europe and China.
The key players covered in this study
AbbVie
Amgen
Merck
Novartis
OPKO Health
…
Market segment by Type, the product can be split into
Bisphosphonates
Glucocorticoids
Calcimimetic Agents
Market segment by Application, split into
Mild Hypercalcemia
Moderate Hypercalcemia
Severe Hypercalcemia
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypercalcemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hypercalcemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypercalcemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bisphosphonates
1.4.3 Glucocorticoids
1.4.4 Calcimimetic Agents
1.5 Market by Application
1.5.1 Global Hypercalcemia Treatment Market Share by Application (2014-2025)
1.5.2 Mild Hypercalcemia
1.5.3 Moderate Hypercalcemia
1.5.4 Severe Hypercalcemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hypercalcemia Treatment Market Size
2.2 Hypercalcemia Treatment Growth Trends by Regions
2.2.1 Hypercalcemia Treatment Market Size by Regions (2014-2025)
2.2.2 Hypercalcemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hypercalcemia Treatment Market Size by Manufacturers
3.1.1 Global Hypercalcemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypercalcemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypercalcemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypercalcemia Treatment Key Players Head office and Area Served
3.3 Key Players Hypercalcemia Treatment Product/Solution/Service
3.4 Date of Enter into Hypercalcemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hypercalcemia Treatment Market Size by Type (2014-2019)
4.2 Global Hypercalcemia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Hypercalcemia Treatment Market Size (2014-2019)
5.2 Hypercalcemia Treatment Key Players in United States
5.3 United States Hypercalcemia Treatment Market Size by Type
5.4 United States Hypercalcemia Treatment Market Size by Application
6 Europe
6.1 Europe Hypercalcemia Treatment Market Size (2014-2019)
6.2 Hypercalcemia Treatment Key Players in Europe
6.3 Europe Hypercalcemia Treatment Market Size by Type
6.4 Europe Hypercalcemia Treatment Market Size by Application
7 China
7.1 China Hypercalcemia Treatment Market Size (2014-2019)
7.2 Hypercalcemia Treatment Key Players in China
7.3 China Hypercalcemia Treatment Market Size by Type
7.4 China Hypercalcemia Treatment Market Size by Application
8 Japan
8.1 Japan Hypercalcemia Treatment Market Size (2014-2019)
8.2 Hypercalcemia Treatment Key Players in Japan
8.3 Japan Hypercalcemia Treatment Market Size by Type
8.4 Japan Hypercalcemia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hypercalcemia Treatment Market Size (2014-2019)
9.2 Hypercalcemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hypercalcemia Treatment Market Size by Type
9.4 Southeast Asia Hypercalcemia Treatment Market Size by Application
10 India
10.1 India Hypercalcemia Treatment Market Size (2014-2019)
10.2 Hypercalcemia Treatment Key Players in India
10.3 India Hypercalcemia Treatment Market Size by Type
10.4 India Hypercalcemia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Hypercalcemia Treatment Market Size (2014-2019)
11.2 Hypercalcemia Treatment Key Players in Central & South America
11.3 Central & South America Hypercalcemia Treatment Market Size by Type
11.4 Central & South America Hypercalcemia Treatment Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypercalcemia Treatment Introduction
12.1.4 AbbVie Revenue in Hypercalcemia Treatment Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypercalcemia Treatment Introduction
12.2.4 Amgen Revenue in Hypercalcemia Treatment Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypercalcemia Treatment Introduction
12.3.4 Merck Revenue in Hypercalcemia Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypercalcemia Treatment Introduction
12.4.4 Novartis Revenue in Hypercalcemia Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 OPKO Health
12.5.1 OPKO Health Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypercalcemia Treatment Introduction
12.5.4 OPKO Health Revenue in Hypercalcemia Treatment Business (2014-2019)
12.5.5 OPKO Health Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hypercalcemia Treatment Key Market Segments
Table Key Players Hypercalcemia Treatment Covered
Table Global Hypercalcemia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hypercalcemia Treatment Market Size Market Share by Type 2014-2025
Figure Bisphosphonates Figures
Table Key Players of Bisphosphonates
Figure Glucocorticoids Figures
Table Key Players of Glucocorticoids
Figure Calcimimetic Agents Figures
Table Key Players of Calcimimetic Agents
Table Global Hypercalcemia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Mild Hypercalcemia Case Studies
Figure Moderate Hypercalcemia Case Studies
Figure Severe Hypercalcemia Case Studies
Figure Hypercalcemia Treatment Report Years Considered
Table Global Hypercalcemia Treatment Market Size 2014-2025 (Million US$)
Figure Global Hypercalcemia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hypercalcemia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Hypercalcemia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Hypercalcemia Treatment Market Share by Regions 2014-2019
Figure Global Hypercalcemia Treatment Market Share by Regions 2014-2019
Figure Global Hypercalcemia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Hypercalcemia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hypercalcemia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Hypercalcemia Treatment Market Share by Manufacturers in 2018
Table Global Hypercalcemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hypercalcemia Treatment Product/Solution/Service
Table Date of Enter into Hypercalcemia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hypercalcemia Treatment Market Size Share by Type (2014-2019)
Figure Global Hypercalcemia Treatment Market Size Market Share by Type (2014-2019)
Table Global Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hypercalcemia Treatment Market Size Share by Application (2014-2019)
Figure Global Hypercalcemia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hypercalcemia Treatment Revenue Market Share by Application in 2018
Figure United States Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table United States Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Hypercalcemia Treatment Market Share by Type (2014-2019)
Table United States Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure Europe Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table Europe Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Hypercalcemia Treatment Market Share by Type (2014-2019)
Table Europe Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure China Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table China Hypercalcemia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Hypercalcemia Treatment Market Share by Type (2014-2019)
Table China Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure Japan Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table Japan Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Hypercalcemia Treatment Market Share by Type (2014-2019)
Table Japan Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table Southeast Asia Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hypercalcemia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure India Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table India Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Hypercalcemia Treatment Market Share by Type (2014-2019)
Table India Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Hypercalcemia Treatment Market Share by Application (2014-2019)
Figure Central & South America Hypercalcemia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hypercalcemia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hypercalcemia Treatment Market Share (2018-2019)
Table Central & South America Hypercalcemia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hypercalcemia Treatment Market Share by Type (2014-2019)
Table Central & South America Hypercalcemia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hypercalcemia Treatment Market Share by Application (2014-2019)
Table AbbVie Company Details
Table AbbVie Revenue in Hypercalcemia Treatment Business (2014-2019) (Million US$)
Figure AbbVie Revenue Growth Rate in Hypercalcemia Treatment Business (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Revenue in Hypercalcemia Treatment Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Hypercalcemia Treatment Business (2014-2019)
Table Amgen Recent Development
Table Merck Company Details
Table Merck Revenue in Hypercalcemia Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Hypercalcemia Treatment Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Hypercalcemia Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Hypercalcemia Treatment Business (2014-2019)
Table Novartis Recent Development
Table OPKO Health Company Details
Table OPKO Health Revenue in Hypercalcemia Treatment Business (2014-2019)(Million US$)
Figure OPKO Health Revenue Growth Rate in Hypercalcemia Treatment Business (2014-2019)
Table OPKO Health Recent Development
Table Global Hypercalcemia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hypercalcemia Treatment Market Size Share by Regions (2019-2025)
Figure Global Hypercalcemia Treatment Market Size Share by Regions in 2025
Figure United States Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hypercalcemia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hypercalcemia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hypercalcemia Treatment Market Size by Product (2019-2025)
Figure Global Hypercalcemia Treatment Market Size by Product in 2025
Table Global Hypercalcemia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hypercalcemia Treatment Market Size by Application (2019-2025)
Figure Global Hypercalcemia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
骨・ミネラル代謝障害治療の世界市場：市場規模・現状・予測 Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…- パジェット病治療の世界市場：市場規模・現状・予測 Paget's disease is a chronic condition which interferes with your body's normal bone remodeling process. ... Over time, the disease can cause affected bones to become fragile and misshapen. Paget's disease of bone most commonly occurs in the pelvis, skull, spine and legs.In 2018, the global Paget's …
- パジェット病治療の世界市場：市場規模・現状・予測 Paget's disease is a chronic condition which interferes with your body's normal bone remodeling process. ... Over time, the disease can cause affected bones to become fragile and misshapen. Paget's disease of bone most commonly occurs in the pelvis, skull, spine and legs.In 2018, the global Paget's …
- 萎縮性胃炎治療の世界市場：市場規模・現状・予測 Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- 鳥インフルエンザ治療の世界市場：市場規模・現状・予測 Avian flu, which is generally known as bird flu, is an infectious viral disease commonly found in waterfowl birds such as ducks and geese. Avian flu is an uncommon disease in humans but can get infected by close contact with infected species.In 2018, the global Avian Flu Treatment market size was xx…